His Startup Bets Shorter-Acting Psychedelics Are the Fastest to Clinics | Sam Banister | 79

Send us Fan Mail

Nick talks to medicinal chemist Sam Banister, who is co-founder and Chief Science Officer at Psylo, a biotech startup focused on developing next-generation psychedelic medicines. They discuss: the past, present, and future of psychedelic science; Sam's journey from academia to biotech startup co-founder; Alexander Shulgin; psychedelics like psilocybin, DMT, and others; and psychedelics & society. 

*Not medical advice.

Support the show

Support my work:

• Good Chemistry: Personalized, science-based health consulting. Work with Dr. Nick Jikomes directly.
• Affiliate Partners: Visit this link to see my affiliate partners and get discounts codes for products & services to support health.

For all the ways you can support my efforts.